Antitumor Imidazolyl Disulfide IV-2 Causes Irreversible G2/M Cell Cycle Arrest without Hyperphosphorylation of Cyclin-Dependent Kinase Cdk1
Authors:
- Kenji TamuraKTKenji Tamura
- Shawndra WatsonSWShawndra Watson
- John S. LazoJLJohn S. Lazo
- 1 September 2000
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 294 (3) , 1070-1075
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mechanisms of Inhibition of the Thioredoxin Growth Factor System by Antitumor 2-Imidazolyl DisulfidesBiochemical Pharmacology, 1998
- Novel Anti-Carcinogenic Activity of an Organosulfide from Garlic: Inhibition of H-RASOncogene Transformed Tumor Growthin Vivoby Diallyl Disulfide Is Associated with Inhibition of p21H-rasProcessingBiochemical and Biophysical Research Communications, 1996
- Dephosphorylation of human p34cdc2 kinase on both Thr‐14 and Tyr‐15 by human cdc25B phosphataseFEBS Letters, 1993
- Superoxide dismutase and thioredoxin restore defective p34cdc2 kinase activation in mouse two-cell blockBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Synthesis and evaluation of imidazolyl disulfides for selective cytotoxicity to hypoxic EMT6 tumor cells in vitroEuropean Journal of Medicinal Chemistry, 1992
- The cdc25 protein contains an intrinsic phosphatase activityCell, 1991
- Possible regulation of the in vitro assembly of bovine brain tubulin by the bovine thioredoxin systemBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene productCell, 1990
- Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin.Journal of Biological Chemistry, 1985
- Enzymatic Synthesis of DeoxyribonucleotidesJournal of Biological Chemistry, 1964